Cardiovascular benefits The SELECT trial a landmark cardiovascular outcomes study involving over 17,000 participants showed that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity who did not have diabetes
Glutamate and functional connectivity Support for the excitatory-inhibitory imbalance hypothesis in autism spectrum disorders
The longest animal studies on BPC-157 span approximately 4 weeks to 12 weeks, leaving the safety profile for use extending beyond 3 months entirely undocumented in peer-reviewed literature
C$60.01SOLD OUT 20MG TIRZEPATIDE A dual GIP and GLP-1 receptor agonist used as a reference compound in laboratory metabolic research
Can this product help with anti-ageing
These might include dietary changes associated with weight loss, stress related to lifestyle modifications, concurrent medications, underlying mental health conditions, or other medical issues